Assignee
PLS DESIGN GMBH
DE·7 granted patents·8 pending applications·28 citations·filing 2004–2017
Top patents by PatentIndex Score
15 records- 0185US7897153B1Chimera of human IgE receptor α-chain and avian constant immuno-globulin domains for the determination of serum IgEPLS DESIGN GMBH·Filed 2006·Granted Mar 1, 2011·13 cites·19 claims
- 0279US10238735B2Controlled activation of complement components for use as endogenous adjuvantPLS DESIGN GMBH·Filed 2013·Granted Mar 26, 2019·3 cites·15 claims
- 0374US7553931B2Complement depletion using recombinant human C3-derivativesPLS DESIGN GMBH·Filed 2004·Granted Jun 30, 2009·11 cites·4 claims
- 0468US7696323B2Bivalent IgY antibody constructs for diagnostic and therapeutic applicationsPLS DESIGN GMBH·Filed 2006·Granted Apr 13, 2010·1 cites·23 claims
- 0557US2014163200A1Method for determining an unknown PNA sequence and uses thereofPLS DESIGN GMBH·Filed 2013·Application pending·0 cites
- 0655US2014178474A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationPLS DESIGN GMBH·Filed 2013·Application pending·0 cites
- 0752US2018117143A1Pharmaceutical composition for treatment of allergic reactionsPLS DESIGN GMBH·Filed 2017·Application pending·0 cites
- 0852US2014335162A1Pharmaceutical composition for treatment of allergic reactionsPLS DESIGN GMBH·Filed 2012·Application pending·0 cites
- 0950US7846690B2Cloning of honey bee allergenPLS DESIGN GMBH·Filed 2005·Granted Dec 7, 2010·0 cites·23 claims
- 1047US2016271257A1Low Molecular Weight Immune-Modulators As Adjuvants for Specific ImmunotherapyPLS-DESIGN GMBH·Filed 2014·Application pending·0 cites
- 1147US2017072048A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationPLS-DESIGN GMBH·Filed 2015·Application pending·0 cites
- 1245US2013337044A1Modulation of effector t cell responses by local depletion of complement component c3PLS DESIGN GMBH·Filed 2013·Application pending·0 cites
- 1344US7888068B2Cloning of honey bee allergen CPLS DESIGN GMBH·Filed 2007·Granted Feb 15, 2011·0 cites·16 claims
- 1441US2016338955A1Antigen-specific immunotherapy using tolerizing liposomesPLS-DESIGN GMBH·Filed 2016·Application pending·0 cites
- 1538US11065330B2Induction of antigen-specific tolerance by peripheral phagocytosisPLS DESIGN GMBH·Filed 2015·Granted Jul 20, 2021·0 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →